A61K 31/5513
1,4-benzodiazepines
Official title: 1,4-Benzodiazepines, e.g. diazepam {or clozapine}
A61K31/5513 (1,4-benzodiazepines) appears on 1,506 US grants and 2,879 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,506
- Published applications
- 2,879
- Assignees
- 1,064
- Inventors
- 4,608
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 4 | 0 |
| 1996 | 6 | 0 |
| 1997 | 10 | 0 |
| 1998 | 27 | 0 |
| 1999 | 18 | 0 |
| 2000 | 14 | 0 |
| 2001 | 15 | 4 |
| 2002 | 21 | 34 |
| 2003 | 26 | 72 |
| 2004 | 41 | 103 |
| 2005 | 20 | 75 |
| 2006 | 54 | 94 |
| 2007 | 12 | 75 |
| 2008 | 21 | 64 |
| 2009 | 18 | 78 |
| 2010 | 26 | 72 |
| 2011 | 21 | 66 |
| 2012 | 29 | 87 |
| 2013 | 35 | 77 |
| 2014 | 66 | 127 |
| 2015 | 79 | 166 |
| 2016 | 83 | 143 |
| 2017 | 96 | 176 |
| 2018 | 95 | 155 |
| 2019 | 117 | 168 |
| 2020 | 94 | 192 |
| 2021 | 87 | 169 |
| 2022 | 80 | 169 |
| 2023 | 83 | 161 |
| 2024 | 76 | 140 |
| 2025 | 76 | 105 |
| 2026 | 47 | 107 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Use of multikinase inhibitor6 Oct 2026US 12,751,957 B2Transthera Sciences (Nanjing), Inc.
- Treatment of inflammatory diseases of the central nervous system29 Sep 2026US 12,746,245 B2Palmaya Pty Ltd
- RUNX1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition15 Sep 2026US 12,735,707 B2Massachusetts Eye and Ear Infirmary
- Degradation of Bruton's tyrosine kinase (BTK) by conjugation of BTK inhibitors with E3 ligase ligand and methods of use8 Sep 2026US 12,729,203 B2BeOne Medicines | GmbH
- Salts of neuroceuticals and uses thereof25 Aug 2026US 12,714,711 B2SyneuRx International (Taiwan) Corp.
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Crystalline forms of evenamide8 Oct 2026US 2026/0308115 A1Newron Pharmaceuticals S.p.A.
- Ketamine for the treatment of menstrually related symptoms1 Oct 2026US 2026/0294843 A1
- Methods for the treatment of childhood-onset fluency disorder1 Oct 2026US 2026/0294924 A1Noema Pharma AG
- Anti-HER2 Antibodies and Immunoconjugates1 Oct 2026US 2026/0297214 A1Genentech, Inc.
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- Abuse-proofed dosage system297US 7,776,314 B2GrüNenthal GmbH · 2010
- Abuse-proofed dosage form249US 8,114,383 B2Gruenenthal GmbH · 2012